This comes just weeks after Lupin secured USFDA approval for its Risperidone Injectable, used to treat schizophrenia and ...

Lupin shares have gained for eight consecutive trading sessions as of Tuesday's close. The last time the stock gained for eight consecutive sessions was between December 23, 2024 to January 1, 2025.

Lupin’s shares rose 2.8% in afternoon trading after the company received a key U.S. Food and Drug Administration (FDA) ...

Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension ...

Risperidone Injectable is the bioequivalent to the reference listed drug (RLD), Risperdal Consta Long-Acting Injection. It is ...

Mumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six ...

Lupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA ...

Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing ...